 Home > Active Ingredient News > Drugs Articles > The Center for Drug Evaluation issued the "Guiding Principles for Clinical Research and Development of Anti-tumor Drugs Oriented by Clinical Value"

The Center for Drug Evaluation issued the "Guiding Principles for Clinical Research and Development of Anti-tumor Drugs Oriented by Clinical Value"

 Last Update: 2021-12-05
 Source: Internet
 Author: User

Tags

printers anti counterfeit

lortab street value

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

In order to implement the clinical value-oriented and patient-centered R&D concept, and promote the scientific and orderly development of anti-tumor drugs, under the deployment of the National Medical Products Administration, the Center for Drug Evaluation has organized and formulated the "Clinical Value-Oriented Anti-tumor Drugs" Guidelines for Clinical Research and Development of Tumor Drugs (see appendix)
.

In accordance with the requirements of the "Notice of the Comprehensive Department of the State Drug Administration on Issuing the Procedures for Issuing the Technical Guidelines for Drugs" (Yao Jian Zong Yao Guan [2020] No.

Hereby inform
.

Attachment: Guiding Principles for Clinical Research and Development of Anti-tumor Drugs Oriented by Clinical Value

National Food and Drug Administration Center for Drug Evaluation

November 15, 2021

The "Clinical Value-Oriented Guiding Principles for the Clinical Research and Development of Anti-tumor Drugs" is released.
Once the guidelines are published, many "Chinese->
.

It also shows that the next step for the pharmaceutical industry to move towards the field of innovation, FIC will be increasingly valued and tilted by capital

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

Tirzepatide Lyophilized powder Vial 5mg 10mg 15mg 20mg 30mg customize 99% Purity with third side checking report

CAS No.: 2023788-19-2

Pharmacy Grade

$50-60/UNIT FOB

Wight loss Lyophilized Semaglutide Petide powder CAS 910463-68-2 with 99.9% purity

CAS No.: 910463-68-2

Pharmacy Grade

$140-175/G FOB

High Quality (E,E,E,E)-Squalene CAS NO 111-02-4 GMP ISO9001 EP Pharma grade Manufacture

CAS No.: 111-02-4

EP Pharma grade

$400-405/KG FOB

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

80 20 company(94)

united states logo(227)

ups united states(221)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.